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Objective: This study aimed to investigate the association between the synaptosomal-associated protein 25 kDa (SNAP-25) 
genotype and performance on the continuous performance test (CPT) in Korean children with attention-deficit/hyperactivity dis-
order (ADHD).
Methods: Eighty-seven children with ADHD (mean age, 9.23±1.99 years) participated in this study. Omission errors, commission 
errors, reaction time, and reaction time variability on the CPT were analyzed. The single-nucleotide polymorphism (SNP) 
rs3746544 (1065 T＞G) of SNAP-25 was genotyped to examine the association with CPT performance.
Results: We found significantly more omission errors on the CPT among children with the TT genotype of SNAP-25 (t=2.56, 
p=0.012) after correcting for multiple testing.
Conclusion: Our results suggest the possible involvement of the SNAP-25 1065 T＞G polymorphism in the inattention phenotype 
in children with ADHD. Further studies with more refined neuropsychological measures and much larger sample sizes are needed 
to confirm our findings.
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INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD), which 
is characterized primarily by symptoms of inattention, im-
pulsivity, and hyperactivity, is the most common neuro-
developmental disorder of childhood.1) ADHD is a com-
plex, polygenic disorder with a heritability estimated at ap-
proximately 80%.1) Previous genetic studies have in-
dicated that the complex interplay of genes related to dop-
amine and norepinephrine regulation in the brain may be 
involved in the etiology of ADHD,2) but the results of 
these studies are variable and inconsistent. One reason for 
the inconsistency in results is the phenotypic hetero-
geneity of the disorder. Several studies have measured 
ADHD symptoms using symptom rating scales that rely 
on reports by parents and teachers. The current Diagnostic 
and Statistical Manual of Mental Disorders, fifth edition 
(DSM-V) and International Statistical Classification of 
Diseases, 10th revision (ICD-10) criteria for the diagnosis 
of ADHD is based on the number of inattention and/or hy-
peractivity/impulsivity symptoms rather than the under-
lying pathophysiology. Prior studies have found that re-
ports by parents and teachers tend to be subjective, and 
therefore there is a need for more objective assessments of 
ADHD symptoms.3) Thus, it would be highly desirable to 
investigate other endophenotypes that rely on objectively 
measured data, such as neuropsychological assessments.4-6) 
Under this background, the impairment of the executive 
attentional system or working memory,7) inattentiveness,3) 
and response inhibition deficits8) have been suggested as 
cognitive endophenotypes suitable for ADHD research.9) 
The continuous performance test (CPT)10) is one of the 
most frequently used measures to evaluate sustained at-
tention, which represents the ability to maintain a tonic 
state of alertness over an extended period of time.11) On the 
CPT, participants are required to detect a rare target 
among rapidly presented non-targets for 10 to 30 minutes. 
From the CPT, the number of omission errors (i.e., failing 
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to respond to a target), commission errors (i.e., responding 
to a non-target), reaction time, and reaction time varia-
bility are computed.10) According to a recent meta-analy-
sis, the CPT has the largest effect size for the diagnosis of 
ADHD,12) and has been considered to be a promising en-
dophenotype for ADHD research.4,13,14)
To date, prior studies on the genetic basis of CPT per-
formance have focused on dopaminergic genes such as the 
dopamine D4 receptor gene (DRD4),15,16) the dopamine 
D5 receptor gene,17) and the dopamine transporter gene 
(DAT1),18) and norepinephrine transporter (NET) genes, 
such as G1287A genotype of the NET gene in Korean chil-
dren with ADHD.19) Recently, genes other than those of 
the major catecholamine systems are gaining attention as 
candidate genes for ADHD. Among these candidate 
genes, synaptosomal-associated protein 25 (SNAP-25) is 
encoded by the SNAP-25 gene, which is located on chro-
mosome 20p 11.2. SNAP-25 plays an essential role in the 
vesicle docking and fusion machinery, mediating the re-
lease of major neurotransmitters from the presynaptic 
membrane into the synaptic cleft.20) In addition, SNAP-25 
is implicated in axonal growth and synaptic plasticity.20,21) 
Polymorphisms in the SNAP-25 gene of both animal mod-
els and humans have been investigated, and the associa-
tion of SNAP-25 with ADHD has been confirmed in many 
linkage studies.22-28) These findings have also been sup-
ported by a meta-analysis.2,29) In animal studies, the dele-
tion of SNAP-25 in the coloboma mouse leads to 50% lower 
SNAP-25 mRNA and protein expression compared to 
wild-type mice, causing hyperactivity symptoms in this 
mouse strain. This finding suggests that the gene encoding 
SNAP-25 might be responsible for hyperkinetic behavior.30) 
In addition, normal dopaminergic transmission was re-
stored by the transgenic rescue of SNAP-25 function.31) In 
a prior human study that used the transmission dis-
equilibrium test, biased transmission of the alleles of 4 
polymorphisms of SNAP-25 (rs6039806, rs362987, 
rs362549, and rs362998) was found in Canadian families 
with ADHD.26) The presumed mechanism underlying the 
hyperactivity of these mice seems to be the possible dysre-
gulation of the release of neurotransmitters in some brain 
regions. In particular, glutamate content and release as 
well as the utilization of dopamine in the neocortex is re-
duced, whereas norepinephrine concentration within the 
striatal structures is increased.20,32)
Among the different polymorphisms identified for the 
SNAP-25 gene, the 1065 T＞G single-nucleotide poly-
morphism (SNP) has received the most attention in prior 
studies of ADHD. For example, in a Korean case-con-
trolled association study by Choi et al.,28) the TG genotype 
of the 1065 T＞G SNP was associated with ADHD. In ad-
dition, it was reported in a meta-analysis that the T allele 
of the 1065 T＞G SNP is significantly associated with 
ADHD (odds ratio, 1.19; 95% confidence interval, 
1.03-1.38).2,33) It was also reported in Mill et al.25) that the 
TT haplotype was disproportionately transmitted to 
ADHD offspring (p=0.01). 
However, there is sparse data in the existing literature re-
garding the association between SNAP-25 genotypes and 
neuropsychological test performance. Therefore, more 
studies are necessary to delineate the roles of the SNAP-25 
gene in the genetic basis of the common cognitive endo-
phenotypes of ADHD.26) The aim of the present study was 
to evaluate the association between SNAP-25 genotypes 
and inattention/impulsivity symptoms as measured by the 
CPT in Korean children and adolescents with ADHD. 
METHODS
Participants
Eighty-seven children with ADHD were recruited from 
the outpatient child and adolescent clinic in a university 
hospital in South Korea. The inclusion criteria were: (1) 
ADHD diagnosis according to the Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition 
(DSM-IV) criteria; (2) aged 6-15 years old; and (3) no his-
tory of psychostimulant or other psychiatric drug use. 
ADHD subjects with comorbid disorders, such as depres-
sive disorder, anxiety disorder, tics or Tourette’s syn-
drome, oppositional defiant disorder, or conduct disorder 
were also included. The exclusion criteria were: (1) an in-
telligence quotient (IQ) score below 70; (2) past or current 
neurological disease; and (3) a diagnosis of autism spec-
trum disorder, learning disorder, or any psychotic spec-
trum disorder, including bipolar disorder. This study was 
approved by the Institutional Review Board of Yonsei 
University College of Medicine (No. 4-2011-0919), and 
informed consent or assent was obtained from the partic-
ipants and their parents or guardians. 
Diagnostic Procedures and Clinical Symptoms Assessment 
The diagnosis of ADHD and comorbid disorders was 
established using the Korean Kiddie-Schedule for Affec-
tive Disorders and Schizophrenia-Present and Lifetime 
version (K-SADS-PL).34) Intellectual abilities were as-
sessed using the Korean version of the Wechsler Intelli-
gence Scale for Children-third edition (K-WISC-III). The 
severity of ADHD symptoms was assessed by the Korean 
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ADHD Rating Scale-IV,35) which was completed by both 
parents and teachers. 
Neuropsychological Assessments: Continuous 
Performance Test 
The Korean version of the computer-based CPT,10) 
which has been named the ADHD Diagnostic System,36) 
was administered to participants to measure neuro-
psychological function. On the CPT, target and non-target 
visual stimuli are rapidly presented at regular intervals on 
a computer screen, and the subject must respond as quick-
ly as possible to target stimuli only. All the results from the 
CPT were automatically scored. The test duration was 10 
minutes for children aged 6 to 7 years old and 15 minutes 
for children older than 7 years old. Subjects were meas-
ured on four indices: 1) the number of omission errors 
(i.e., failure to respond to a target), as an indicator of in-
attention; 2) the number of commission errors (i.e., re-
sponse to a non-target), as an indicator of hyperactivity or 
impulsivity; 3) reaction time (i.e., response times for cor-
rect responses to target stimuli), as an indicator of process-
ing speed; and 4) reaction time variability (i.e., the stand-
ard deviation [SD] of reaction time). The raw data from 
the four outcome variables were converted to age-ad-
justed T-scores, which are scaled to a mean of 50 and a SD 
of 10. The percentage of correct classifications on the 
Korean version of the computer-based CPT is 96.7% and 
its reliability is 0.85.36)
SNAP-25 (rs) Genotyping 
Genomic DNA was extracted from blood lymphocytes 
using a genomic DNA extraction kit (Bioneer, Daejon, 
Korea) according to the manufacturer’s protocol. SNP 
identification was based on an analysis of primer ex-
tension products obtained from previously amplified ge-
nomic deoxyribonucleic acid (DNA) using a chip-based 
Matrix-Assisted Laser Desorption/Ionization Time-of- 
Flight (MALDI-TOF) mass spectrometry platform 
(Sequenom, Inc., San Diego, CA, USA). The procedures 
were performed according to the manufacturer’s standard 
protocol. 
Oligonucleotide primers (5’- ACG TTG GAT GTT 
TTC CAG GTC TGA CAA CGG and 5’- ACG TTG GAT 
GAC CCA GCG GAT GGT GGA TTT) were used to gen-
erate polymerase chain reaction (PCR) products. Amplifi-
cation of the PCR reaction was performed in a volume of 5 
L containing 1X PCR buffer (TAKARA, Shiga, Japan), 
2.5 mmol/L magnesium chloride, 0.2 mmol/L each of de-
oxyribonucleotide triphosphate, 0.1 U HotStar Taq 
Polymerase (Quiagen GmbH, Hilden, Germany), 8 
pmol/L of each primer, and 4.0 ng of genomic DNA. The 
PCR reaction consisted of denaturation at 95oC for 15 mi-
nutes followed by 45 cycles of 95oC for 20 seconds, 56oC 
for 30 seconds, and 72oC for 1 minutes, with a final ex-
tension at 72oC for 3 minutes. 
Statistical Analyses
Descriptive statistics were obtained to evaluate the 
demographic and clinical characteristics of the partici-
pants. Group differences in continuous demographic and 
clinical variables were computed using independent 
two-sample t-tests. Between-group comparisons on cate-
gorical variables were assessed using the χ2 test or 
Fisher’s exact test. The allele frequency was determined, 
and the Hardy-Weinberg equilibrium was calculated using 
a goodness-of-fit χ2 test. Due to the small number of par-
ticipants with the SNAP-25 GG genotype, the sample was 
divided according to whether the rare G allele was present 
or not. To investigate the association between the 
SNAP-25 genotype and performance on the CPT, we used 
the SNAP-25 genotype (TT versus TG or GG) as the main 
predictor. Independent t-tests were used to compare the 
differences in the CPT measures by genotype. All stat-
istical analyses were performed using the IBM SPSS 
Statistics ver. 22.0 (IBM Co., Armonk, NY, USA). The 
level of significance was set at p=0.05 (two-tailed). 
RESULTS
Demographic and Clinical Characteristics
Of the 87 children with ADHD initially enrolled, 72 
were boys (82.8%), and the mean age of the ADHD sub-
jects was 9.23 years old (SD, 1.99). Thirty-nine subjects 
(44.8%) were diagnosed with the ADHD combined type, 
40 (46.0%) with the ADHD inattentive type, and 8 (9.2%) 
with the ADHD hyperactive/impulsive type. The average 
total score on the ADHD symptom rating scale as meas-
ured by the parents was 32.19 (SD, 8.01). Table 1 reports 
the demographic and clinical characteristics of the partic-
ipants according to their SNAP-25 genotype. We found no 
significant between-group differences in age, sex, IQ, co-
morbidity, or baseline ADHD-rating scale scores. 
SNAP-25 Genetic Polymorphisms 
Genotype analysis of the SNAP-25 polymorphism iden-
tified the TT genotype in 52 subjects (59.8%), the TG gen-
otype in 31 subjects (35.6%), and the GG genotype in the 
remaining 4 subjects (4.6%). The genotype distribution of 
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Table 1. Comparison of demographic and clinical characteristics according to the SNAP-25 genotype in Korean children with ADHD
Characteristic Total (n=87) T/T (n=52) T/G+G/G (n=35) p value
Age (yr) 9.23±1.99 9.35±2.18 9.06±1.70 0.510
Male 72 (81.8) 44 (84.6) 28 (80.0) 0.578*
FSIQ 104.79±16.25 103.81±16.73 106.26±15.62 0.575†
ADHD subtype
Combined 39 (44.3) 2 (35.7) 16 (45.7)
Inattentive 40 (45.5) 24 (46.2) 16 (45.7) 0.982*
Hyperactive/impulsive 8 (9.2) 5 (9.6) 3 (8.6)
Comorbidity
Conduct disorder  2 (2.3) 1 (1.4) 1 (2.3) 1.000*
ODD 2 (2.3) 2 (3.8) 0 (0) 0.354*
Depressive disorder 18 (20.4) 9 (17.3)  9 (25.7) 0.382*
Anxiety disorder 10 (11.3) 7 (12.8) 3 (8.6) 0.252*
Tics or Tourette’s syndrome 8 (9.1) 2 (3.8) 6 (11.4) 0.747*
ARS baseline scores
Total 32.19±8.01 32.00±8.01 32.66±7.86 0.706†
Inattentive 16.84±4.11 16.31±4.15 16.34±3.95 0.143†
Hyperactive/impulsive 15.42±6.37 15.69±6.87 15.03±5.61 0.636†
Values are presented as mean±stdandard deviation or number (%).
ADHD, attention-deficit/hyperactivity disorder; FSIQ, full scale intelligence quotient; ODD, oppositional defiance disorder; MPH, methyl-
phenidate; ARS, ADHD Rating Scale. 
*Calculated by a one-way analysis of variance test. †Calculated by 2 test or Fisher’s exact test.
Table 2. Comparison of four performance measures on the CPT according to the SNAP-25 1065 T>G genotype
CPT performance measure
1065 T＞G genotypes of SNAP 25 (mean±SD)
t p value
T/T (n=52) T/G+G/G (n=35)
Omission errors 66.90±37.62 50.31±8.80 2.558 0.012
Commission errors 72.77±37.24 61.37±22.89 1.615 0.110
Reaction time 54.77±16.40 54.49±13.29 0.085 0.932
Reaction time variability 69.94±27.59 64.60±20.85 0.973 0.333
CPT, continuous performance test. 
The results of the χ2 test are reported. The significance level was set to p＜0.05.
the SNAP-25 polymorphisms were in agreement with the 
expected values of the Hardy-Weinberg equilibrium (p＞
0.05), and were similar to the previously reported refer-
ence values in a Korean ADHD population (56.8% for TT, 
36.7% for TG, and 6.5 % for GG) (Table 1).37)
Comparison of CPT Performance Across Genotypes
As shown in Table 2, we found a significant difference 
in omission errors on the visual CPT between the TT and 
TG+GG genotype groups (t=2.558, p=0.012). Children 
with ADHD possessing the TT genotype made more 
omission errors than those with either the TG or GG geno-
types; this association remained significant after correct-
ing for multiple test sessions (corrected p value=0.05/4 
subtests=0.0125). No significant differences were found 
in other CPT measures between the two genotype groups 
(Table 2). 
DISCUSSION
We found a significant association between the 
SNAP-25 1065 T＞G genotype and omission errors on the 
CPT among Korean children with ADHD. Children with 
ADHD having the TT genotype made more omission er-
rors on the visual CPT compared to those with the TG or 
GG genotype. Omission errors on the CPT are interpreted 
as a measure of inattention, and have been proposed as a 
putative endophenotype to index genetic variability in 
ADHD.4) Our results suggest that variations in the in-
attention phenotype may be related to genetic variations in 
the SNAP-25 gene.
The association between the SNAP-25 genotype and 
neuropsychological measures of executive functioning, 
such as performance on the CPT, is consistent with prior 
studies that have reported a link between SNAP-25 and 
deficient learning and information processing in the colo-
boma mouse.38) These learning processes in the mouse are 
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somewhat similar to attention processes in humans.38) In 
addition to results from animal studies, previous studies in 
humans have found an association between SNAP-25 gen-
otypes and cognitive variables in other neuropsychiatric 
disorders with impaired executive function. Specifically, 
an association has been found between cognitive dysfunc-
tion and the DdeI polymorphism of the SNAP-25 gene 
among Caucasian patients with schizophrenia who were 
undergoing treatment with atypical antipsychotics.39) In 
addition, the rs363050 SNP of SNAP-25 has been asso-
ciated with low cognitive scores in autistic children.40) 
Recent studies have also suggested the possible involve-
ment of SNAP-25 in learning, memory, and intelligence in 
normal healthy control participants.41) 
However, research on the relationship between 
SNAP-25 polymorphisms and cognitive variables among 
ADHD patients is scarce in the existing literature. Most 
significant associations between genotypes and CPT 
measures that have been reported in the literature involve 
genes for the catecholamine system. For example, one 
study has reported an association between the 4-repeat al-
lele of the DRD4 gene and fewer commission errors and 
less reaction time variability on the CPT.15) In another study, 
Korean ADHD subjects with the T allele of the –3081 poly-
morphism of the NET gene exhibited a trend toward more 
reaction time variability on the CPT than those with the A/A 
genotype, whereas no differences were found between two 
groups with different G1287A polymorphisms.42)
There is some evidence in the literature that the 
SNAP-25 genotype is associated with either ADHD or 
treatment response in patients with ADHD. According to 
the study by Choi et al.,28) there was a significant difference 
between ADHD cases and controls for the 1065 poly-
morphism (MnlI polymorphism; rs3746544) (χ2=9.57, 
degree of freedom=2, p=0.008); there was a higher fre-
quency of homozygotes (i.e., TT and GG) among ADHD 
subjects and a higher frequency of heterozygotes (TG) 
among control subjects.28) This result is partially con-
sistent with our results, in that subjects with the TT geno-
type had more omission errors on the CPT than those with 
the TG or GG genotypes. When we consider more omis-
sion errors as an ADHD trait, the homozygous TT geno-
type seems to exert a greater effect for the ADHD trait. 
One possible explanation for this phenomenon is that ho-
mozygotes produce too much (i.e., over-expression) or 
too little (i.e., under-expression) protein for optimal bio-
logical activity, thereby disrupting neural function.28) In 
contrast, the G genotype may have a protective role 
against the development of an ADHD trait, because heter-
ozygotes may produce just the right amount of protein for 
normal neural function.43) 
Currently, the functional significance of the SNAP-25 
1065 T＞G polymorphism is unknown. However, it is as-
sumed that this polymorphism does not influence the en-
coding of protein variants or SNAP-25 expression di-
rectly, because this SNP is located in the 3’ untranslated 
region of the SNAP-25 genes.22) Based on the results of the 
current study, the 1065 T＞G polymorphism may modu-
late the expression of SNAP-25. The association found in 
this study may also indicate a linkage disequilibrium with 
a functionally relevant variation in the coding or regu-
latory region of SNAP-25. In addition, there exists the 
possibility that this SNP represents an important site for 
mRNA stability and translational efficiency.44) Taken to-
gether, it is plausible that the 1065 T＞G polymorphism 
plays a role in the expression and regulation of the 
SNAP-25 gene, and may enhance susceptibility to ADHD. 
Other studies have reported that the SNAP-25 gene 
modifies the release of neurotransmitters.31) There is some 
evidence that genetic variation may lead to lower levels of 
SNAP-25 through transcriptional regulation, which 
would ultimately lead to the decreased exocytosis of sev-
eral neurotransmitters, including dopamine.45) In our 
study, individuals with the TT allele presumably have rel-
atively fewer available synaptic catecholamine neuro-
transmitters, and thus perform more poorly on neuro-
psychological measures of executive function than do in-
dividuals with the TG or GG allele. 
In this study, the SNAP-25 polymorphism was only as-
sociated with omission errors, but not with other measures 
of the CPT, such as commission error or response time 
variability. It is possible that different genes may be im-
plicated in different intermediate phenotypes, and our re-
sults suggest that SANP-25 variants may be closely linked 
to the intermediate phenotype of inattention. The findings 
from our study are in contrast to what might be expected 
from the coloboma mouse model, in which it would be hy-
pothesized that the SNAP-25 polymorphism contributes to 
the hyperactivity phenotype. However, inattention, which 
is a hallmark characteristic of ADHD in humans, cannot 
be directly examined in the coloboma mouse model. The 
investigation of cognitive phenotypes is therefore a sig-
nificant limitation of ADHD animal models.46) Further 
studies are needed to explore the relationship between the 
SNAP-25 genotype and ADHD behavioral phenotypes in 
both animal models and humans. 
There were several limitations to our study. First, our 
sample size was small, which limits the statistical power to 
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detect significant group differences. Further studies using a 
larger sample size are necessary to replicate our findings. 
Second, we did not compare SNAP-25 polymorphisms in 
subjects with ADHD and those in control subjects. 
Although the frequency of SNAP-25 polymorphisms in our 
study was similar to those reported in previous studies with 
Korean ADHD and control subjects,28) lack of control group 
presents some methodological limitations, and our results 
should be interpreted with caution. Third, incomplete genet-
ic coverage is another limitation. In our study, only one 
well-known polymorphism, rs3746544(1065 T＞G) of 
SNAP-25, in previous studies of childhood ADHD has 
been examined, but it is unlikely that only one poly-
morphism influences inattention phenotype as measured by 
the CPT. Accordingly, it is possible that our results may be 
affected by other risk mutations of SNAP-25. Therefore, 
our findings need to be confirmed by further large-scale 
studies using tagged SNPs, which cover the entire gene re-
gion of SNAP-25, in a more comprehensive gene set. 
Fourth, demographic and clinical variables that may affect 
CPT results, such as age, IQ, and comorbidities were not 
controlled in this study. However, clinical variables are not 
likely to have affected our results, because these variables 
were not significantly different between the SNAP-25 gen-
otype groups. Fifth, the use of the CPT as a clinical test for 
ADHD is controversial. The inattention phenotype ob-
served in subjects with ADHD is a complex phenomenon 
involving several brain areas. In contrast, the CPT involves 
simple visual stimuli, and results from older subjects and 
those with high IQs have suggested the difficulty of dis-
crimination on the CPT.47,48) However, the CPT , produces 
relatively consistent results compared with other objective 
neuropsychological test measures. In addition, the CPT is 
widely used in both the clinical and research setting due to 
its proven reliability and validity and standardization in 
Korean population.36)
Despite these limitations, to the best of our knowledge, 
our study offers the first comparative analysis of CPT per-
formance according to the SNAP-25 1065 T＞G genotype 
in Korean children with ADHD. Further studies with more 
refined neuropsychological measures and larger sample 
sizes are needed to confirm our findings. 
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